KCTD12 and breast carcinoma: Besides, molecular biologic experiments showed that downregulation of KCTD12 can enhance the G1/S transition through activating the AKT/FOXO1 signaling; especially, knockdown of FOXO1 can restore the inhibitory effect of KCTD12 on cell proliferation of breast cancer.